Characteristics, clinical course, and in-hospital mortality of non-insulin-dependent diabetic and nondiabetic patients with acute myocardial infarction in Argentina

Journal of Diabetes and its Complications

Volumn 11, Issue 3, 1997, Pages 163-171

  Gagliardino, Juan J ^a   Werneke, Ursula ^b   Olivera, Ercilia M ^b   Assad, Daniel ^b   Regueiro, Fernando ^b   Diaz, Rafael ^b   Pollola, Juan ^b   Paolasso, Ernesto ^b  

^a University of La Plata CONICET   (Argentina)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ANGINA PECTORIS; ARGENTINA; ARTICLE; CARDIOGENIC SHOCK; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FATALITY; FEMALE; GENDER; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SHOCK;

EID: 0030957729     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(96)00002-5     Document Type: Article

References (50)

1. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care 2:120-126, 1979.
2. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall Study. BMJ 287:867-870,1983.
3. Jarrett RJ: Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease: Chicken, egg or neither? Diabetologia 26:99-102, 1984.
4. Uusitupa M, Silitonen O, Aro A, Pyorälä K: Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 28:22-27, 1985.
5. American Diabetes Association: Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes (Consensus statement). Diabetes Care 12:573-579, 1989.
6. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H: A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: Causes and death rates. Diabetologia 33:538-541, 1990.
7. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H: A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: Associated risk factors. Diabetologia 33:542-548, 1990.
8. Fontbonne A: Relationship between diabetic dyslipoproteinaemia and coronary heart disease risk in subjects with non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 7:179-189, 1991.
9. Ford ES, DeStefano F: Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes: Findings from the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Am J Epidemiol 133:1220-1230, 1991.
10. Donahue RP, Orchard TJ: Diabetes mellitus and macrovascular complications: An epidemiological perspective. Diabetes Care 15:1141-1155, 1992.
11. Koskinen P, Mänttäri M, Manninen V, Huttunen JK, Heinonen OP, Frick MH: Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 15:820-825, 1992.
12. Tansey MJB, Opie LH, Kennelly BM: High mortality in obese women: Diabetics with acute myocardial infarction. BMJ 25:1624-1626, 1977.
13. Czyzk A, Krölewski AS, Szablowska S, Alot A, Kopezynski J: Clinical course of myocardial infarction among diabetic patients. Diabetes Care 3:526-529, 1980.
14. Barrett-Connor E, Wingard DL: Sex differential in ischemic heart disease mortality in diabetics: A prospective population-based study. Am J Epidemiol 118:489-495, 1983.
15. Singer DE, Moulton AW, Nathan DM: Diabetic myocardial infarction: Interaction of diabetes with other preinfarction risk factors. Diabetes 38:350-357, 1983.
16. Gwilt DJ: Why do diabetic patients die after myocardial infarction? Practical Diabetes 1:36-39, 1984.
17. Gwilt DJ, Petri M, Lewis PW, Natrass M, Pentecost BL: Myocardial infarct size and mortality in diabetic patients. Br Heart J 54:466-472, 1985.
18. Rytter L, Troelsen S, Beck-Nielsen H: Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 8:230-234, 1985.
19. Molstad P, Nustad M: Acute myocardial infarction in diabetic patients. Acta Med Scand 28:433-437, 1987.
20. Yudkin JS, Oswald GA: Determinants of hospital admission and case fatality in diabetic patients with myocardial infarction. Diabetes Care 11:351-358, 1988.
21. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi AG, Stauss HW, Willerson JT, Braunwald E, Jaffe AS and the MILIS Study Group: The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 14:49-59, 1989.
22. Cooper RS, Pacold IV, Ford ES: Age-related differences in case-fatality rates among diabetic patients with myocardial infarction: Findings from National Hospital Discharge Survey, 1979-1987. Diabetes Care 14:903-909, 1991.
23. Sprafka JM, Burke GL, Folsom AR, McGovern PG, Hahn LP: Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival: The Minnesota Heart Survey. Diabetes Care 14: 537-543, 1991.
24. Fava S, Azzopardi J, Muscat HA, Fenech FF: Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 16:1615-1618, 1993.
25. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: The Framingham Study. Circulation 59:9-11, 1979.
26. Heyden S, Heiss G, Bartel AG, Hames CG: Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chron Dis 33:265-273, 1980.
27. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs women: The Framingham Study. JAMA 260:3456-3460, 1988.
28. Greenland P, Reicher-Reiss H, Behar S and the Israeli SPRINT Investigators: In-hospital and 1-year mortality in 1524 women after myocardial infarction: comparison between 4315 men. Circulation 83:484-491, 1991.
29. King H, Rewers M: WHO ad hoc Diabetes Reporting Group. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16:157-177, 1993.
30. Moshkovitz Y, Sclarovsky S, Behar S, Reicher-Reiss H, Kapansky E, Goldbourt U and the SPRINT study group: Infarct site-related mortality in patients with recurrent myocardial infarction. Am J Med 94:388-394, 1993.
31. The International Study Group: In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. Lancet 336:71-75, 1990.
32. Gruppo Italiano per lo Studio della Sopravvivenza nell Infarto Miocardico: GISSI-2: A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,400 patients with acute myocardial infarction. Lancet 336:65-71, 1990.
33. World Health Organization (WHO): WHO Expert Committee on Diabetes Mellitus: Second Report. Geneva, WHO, (Technical Report Series no. 727) 1985.
34. Hohaloser SH, Zakel M, Kasper W, Meinertz T, Just H: Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. J Am Coll Cardiol 18:44-49, 1991.
35. Selvin S: Statistical Analysis of Epidemiologic Data. New York, Oxford University Press, 1991.
36. Hernández RE, Cardonnet LJ, Libman C, Gagliardino JJ: Prevalence of diabetes and obesity in an urban population of Argentina. Res Clin Pract 3:277-283, 1987.
37. Gagliardino JJ, Olivera EM: Aspectos socioeconómicos de la diabetes mellitus en la Argentina: Diagnóstico epidemiológico, in Lemus JD (ed), Epidemiología y Attencion de la Salua en la Argentina. Buenos Aires: OPS, AMA (Publicación 35) 1993, pp. 129-144.
38. Killip T III, Kimball JT: Treatment of myocardial infarction in a coronary care unit: A two year experience with 250 patients. Am J Cardiol 20:457-464, 1967.
39. Sobel BE, Bresnahan GF, Shell WE, Yoder RD: Estimation of infarct size in man and its relation to prognosis. Circulation 46:640-648, 1972.
40. Braunwald E: Myocardial reperfusion, limitation of infarct size, reduction of left ventricular disfunction, and improved survival: Should the paradigm be expanded? Circulation 79:441-444, 1989.
41. Rennert Y, Saltz-Rennert H, Wanderman K, Weitzman S: Size of acute myocardial infarct in patients with diabetes mellitus. Am J Cardiol 55:1629-1630, 1985.
42. The GUSTO Investigation: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673-682, 1993.
43. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG: Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 Study. J Am Coll Cardiol. 22:1788-1794, 1993.
44. Vigorita VJ, Moore GW, Hutchins GM: Absence of correlation between coronary arterial atheroslerosis and severity of duration of diabetes mellitus of adult onset. Am J Cardiol 46:535-542, 1980.
45. Waller BF, Palumbo PJ, Lie JT, Roberts WC: Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years: Analysis of 229 diabetic patients with and without clinical evidences of coronary heart disease and comparison to 183 control subjects. Am J Med 69:498-506, 1980.
46. Gauda OP, Arkin CF: Hyperfibrinogenemia: An important risk factor for vascular complications in diabetes. Diabetes Care 15:1245-1250, 1992.
47. Schneider SH, Kim HC, Khachadurian AK, Ruderman N: Impaired fibrinolytic response to exercise in type II diabetes: Effects of exercise and physical training. Metabolism 37:924-929, 1988.
48. Hornsby WG, Boggess KA, Lyons TJ, Barnwell WH, Lazarchikcs J, Colwell JA: Homeostatic alterations with exercise conditioning in NIDDM. Diabetes Care 13:87-92, 1990.
49. Colwell JA, Halushka PV, Sarji KE, Lopez-Virella MF, Sagel J: Diabetic vascular disease: pathophysiologic mechanisms and therapy. Arch Intern Med 139:225-230, 1979.
50. Jones RL, Peterson CM: The fluid phase of coagulation and the accelerated atherosclerosis of diabetes mellitus. Diabetes 30 (suppl 2):33-38, 1981.